Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03356125

Ligand	Ligand name	Chain	PDB	Tanimoto
OAP	4-(S)-[(1-OXO-7-PHENYLHEPTYL)AMINO]-5-[4-(PHENYLMETHYL)PHENYLTHIO]PENTANOIC ACID	A,B,C,D,E,F	1KVO	0.7
GPS	(9S,10S)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE	A,B	2GST	0.73
GPS	(9S,10S)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE	A,B	6GSW	0.73
GPS	(9S,10S)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE	A,B	6GSV	0.73
GPS	(9S,10S)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE	A	1B4P	0.73
GPS	(9S,10S)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE	A,B	6GSX	0.73
GPS	(9S,10S)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE	A,B	6GSU	0.73
GGC	1-MENAPHTHYL GLUTATHIONE CONJUGATE	A,B	3LJR	0.75
HYB	[2-(2-METHYL-PROPANE-2-SULFONYLMETHYL)-3-NAPHTHALEN-1-YL-PROPIONYL-VALINYL]-PHENYLALANINOL	A	1FMB	0.78
VS2	3-[N-[BENZYLOXYCARBONYL]-PHENYLALANINYL-AMINO]-5-PHENYL-PENTANE-1-SULFONYLMETHYLBENZENE	A	1F2A	0.73
GBX	2-AMINO-4-[1-(CARBOXYMETHYL-CARBAMOYL)-2-(9-HYDROXY-7,8-DIOXO-7,8,9,10-TETRAHYDRO-BENZO[DEF]CHRYSEN-10-YLSULFANYL)-ETHYLCARBAMOYL]-BUTYRIC ACID	A,B	4PGT	0.73
GBX	2-AMINO-4-[1-(CARBOXYMETHYL-CARBAMOYL)-2-(9-HYDROXY-7,8-DIOXO-7,8,9,10-TETRAHYDRO-BENZO[DEF]CHRYSEN-10-YLSULFANYL)-ETHYLCARBAMOYL]-BUTYRIC ACID	A,B	3PGT	0.73
GBX	2-AMINO-4-[1-(CARBOXYMETHYL-CARBAMOYL)-2-(9-HYDROXY-7,8-DIOXO-7,8,9,10-TETRAHYDRO-BENZO[DEF]CHRYSEN-10-YLSULFANYL)-ETHYLCARBAMOYL]-BUTYRIC ACID	A,B	1F3B	0.73
GBX	2-AMINO-4-[1-(CARBOXYMETHYL-CARBAMOYL)-2-(9-HYDROXY-7,8-DIOXO-7,8,9,10-TETRAHYDRO-BENZO[DEF]CHRYSEN-10-YLSULFANYL)-ETHYLCARBAMOYL]-BUTYRIC ACID	A,B	1ML6	0.73
PG1	PENICILLIN G ACYL-SERINE	A,B	1XA7	0.73
PG1	PENICILLIN G ACYL-SERINE	A	2IWC	0.73
PG1	PENICILLIN G ACYL-SERINE	A,B	1MWT	0.73
PNM	OPEN FORM - PENICILLIN G	A	1GHP	0.71
PNM	OPEN FORM - PENICILLIN G	A	1PWC	0.71
PNM	OPEN FORM - PENICILLIN G	A	1IYQ	0.71
PNM	OPEN FORM - PENICILLIN G	A	1FQG	0.71
PNM	OPEN FORM - PENICILLIN G	A,B,C,D	2J8Y	0.71
PNM	OPEN FORM - PENICILLIN G	A,B,C,D	2JBF	0.71
PNM	OPEN FORM - PENICILLIN G	A	2EX8	0.71
PP5	METHYL (2S)-[1-((N-(NAPHTHALENEACETYL))-L-VALYL)AMINOMETHYL)HYDROXYPHOSPHINYLOXY]-3-PHENYL PROPANOATE	A	2WEC	0.71
BAY		B	1VIK	0.73
BAY		A	1VIJ	0.73
AO1	(2S,3R)-3-AMINO-2-HYDROXY-5-(ETHYLSULFANYL)PENTANOYL-((S)-(-)-(1-NAPHTHYL)ETHYL)AMIDE	A	1R5G	0.74
SUB	3-PHENYL-2-{[4-(TOLUENE-4-SULFONYL)-THIOMORPHOLINE-3-CARBONYL]-AMINO}-PROPIONIC ACID ETHYL ESTER	A	1J4H	0.76
VS1	3-[[N-[MORPHOLIN-N-YL]-CARBONYL]-PHENYLALANINYL-AMINO]-5- PHENYL-PENTANE-1-SULFONYLBENZENE	A	2P86	0.71
VS1	3-[[N-[MORPHOLIN-N-YL]-CARBONYL]-PHENYLALANINYL-AMINO]-5- PHENYL-PENTANE-1-SULFONYLBENZENE	A,B,C	1F29	0.71
739	2(S)-{2(S)-[2(R)-AMINO-3-MERCAPTO]PROPYLAMINO-3(S)-METHYL}PENTYLOXY-3-PHENYLPROPIONYLMETHIONINE SULFONE	A,B	1JCQ	0.78
G23	(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID	A	1HTE	0.7
GPR	(9R,10R)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE	A,B	1MTC	0.73
GPR	(9R,10R)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE	A,B	5FWG	0.73
GPR	(9R,10R)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE	A,B	2PGT	0.73
GPR	(9R,10R)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE	A,B	3FYG	0.73
GPR	(9R,10R)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE	A,B	3GST	0.73
LLG	2-aminoethyl naphthalen-1-ylacetate	A	3BC4	0.75
PP6	METHYL[CYCLO-7[(2R)-((N-VALYL)AMINO)-2-(HYDROXYL-(1S)-1-METHYLOXYCARBONYL-2-PHENYLETHOXY)PHOSPHINYLOXY-ETHYL]-1-NAPHTHALENEACETAMIDE]	A	2WED	0.7
PP6	METHYL[CYCLO-7[(2R)-((N-VALYL)AMINO)-2-(HYDROXYL-(1S)-1-METHYLOXYCARBONYL-2-PHENYLETHOXY)PHOSPHINYLOXY-ETHYL]-1-NAPHTHALENEACETAMIDE]	A	2WEA	0.7